Marine Derived Drugs – our new study reveals trends, R&D progress, and predicted revenues Where is the Marine Derived Drugs market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.
Discover How to Stay Ahead Our 172-page report provides 161 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Marine Derived Drugs market. See how to exploit the opportunities.
Forecasts to 2027 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets Along with revenue prediction for the overall world market, there are 3 segmentations of the marine-derived drugs market, with forecasts for 4 Marine Derived Drug Types, 3 Sources and 5 Applications, each forecasted at a global and regional level.
Global Marine-Derived Drugs Market by Type • Steroid • Ether • Peptide • Other
Global Marine-Derived Drugs Market by Source • Algae • Invertebrates • Microorganisms
Global Marine-Derived Drugs Market by Application • Anti-microbial • Anti-tumour • Anti-cardiovascular • Anti-viral • Anti-inflammatory • Other
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 7 regional and 17 leading national markets:
• North America: • US • Canada • Mexico
• South America: • Brazil • Argentina • Paraguay • Bolivia • Rest of South America
• Europe: • Germany • The UK • Italy • Spain • France • Rest of Europe
• Asia-Pacific: • Japan • China • India • Australia • Thailand • Rest of Asia-Pacific
• Rest of the World: • Middle East • Africa • Other Countries
The report also includes profiles and for some of the leading companies in the Marine Derived Drugs market, with a focus on this segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and Australia in particular, will continue to achieve high revenue growth to 2027.
Leading companies and the potential for market growth Overall world revenue for Marine Derived Drugs will surpass $9.3bn in 2017, our work calculates. We predict strong revenue growth through to 2027.
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Marine Derived Drugs Market report helps you In summary, our 172-page report provides you with the following knowledge: • Revenue forecasts to 2027 for 3 segmentations of the marine-derived drugs market, with forecasts for 4 Marine Derived Drug Types, 3 Sources and 5 Applications, each forecasted at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues • Revenue forecasts to 2027 for 7 regional and 17 key national markets – See forecasts for the marine-derived drugs market in North America, South America, Europe, Asia-Pacific, the Middle East, Africa and Other Countries. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Bolivia, Paraguay, Germany, France, the UK, Italy, Spain, China, India, Japan, Australia and Thailand • Discussion of what stimulates and restrains companies and the market • Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Marine Derived Drugs market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Marine Derived Drugs market and leading companies. You will find data, trends and predictions.
Get our report today World Marine Derived Drugs Market Forecast 2017-2027: Prospects by Drug Type (Phenol, Steroid, Ether, Peptide, Other), Source (Algae, Invertebrate, Microorganism), Application (Anti-Microbial, Anti-Tumour, Cardiovascular, Anti-Viral, Anti-Inflammatory), and Geography.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 Marine Derived Drugs Overview 1.2 Research Methodology 1.2.1 Primary Research 1.2.2 Secondary Research 1.2.3 Market Evaluation & Forecasting Methodology 1.3 Global Marine-Derived Drugs Market Segmentation 1.4 Overview of Findings 1.5 Why You Should Read This Report 1.6 How This Report Delivers 1.7 Key Questions Answered by This Analytical Report 1.8 Frequently Asked Questions (FAQ) 1.9 Who is This Report For? 1.10 Associated Visiongain Reports 1.11 About Visiongain
2. Introduction to the Marine-Derived Drugs Market
3. Global Marine-Derived Drugs Market Forecast to 2027 3.1 Marine-Derived Drugs Market by Type 3.2 Marine-Derived Drugs Market by Source 3.3 Marine-Derived Drugs Market by Application
4. Marine-Derived Drugs Market by Type: Market Forecast to 2027 4.1 Overview 4.2 Marine-Derived Phenol Drugs: Market Forecast to 2027 4.3 Marine-Derived Steroid Drugs: Market Forecast to 2027 4.4 Marine-Derived Ether Drugs: Market Forecast to 2027 4.5 Marine-Derived Peptide Drugs: Market Forecast to 2027 4.6 Other Marine-Derived Drugs: Market Forecast to 2027
6. Marine-Derived Drugs Market by Application: Market Forecast, 2017-2027 6.1 Marine-Derived Anti-Microbial Drugs: Market Forecast to 2027 6.2 Marine-Derived Anti-Tumour Drugs: Market Forecast to 2027 6.3 Marine-Derived Cardiovascular Drugs: Market Forecast to 2027 6.4 Marine-Derived Anti-Viral Drugs: Market Forecast to 2027 6.5 Marine-Derived Anti-Inflammatory Drugs: Market Forecast to 2027
7. Leading National Markets, 2017-2027 7.1 Geographical Breakdown of the Global Marine-Derived Drugs Market 7.2 North America Marine-Derived Drugs Market Forecast, 2017-2027 7.2.1 USA Marine-Derived Drugs Market Forecast, 2017-2027 7.2.2 Canada Marine-Derived Drugs Market Forecast, 2017-2027 7.2.3 Mexico Marine-Derived Drugs Market Forecast, 2017-2027 7.3 South America Marine-Derived Drugs Market Forecast, 2017-2027 7.3.1 Brazil Marine-Derived Drugs Market Forecast, 2017-2027 7.3.2 Argentina Marine-Derived Drugs Market Forecast, 2017-2027 7.3.3 Paraguay Marine-Derived Drugs Market Forecast, 2017-2027 7.3.4 Bolivia Marine-Derived Drugs Market Forecast, 2017-2027 7.3.5 Rest of South America Marine-Derived Drugs Market Forecast, 2017-2027 7.4 European Marine-Derived Drugs Market Forecast, 2017-2027 7.4.1 Germany Marine-Derived Drugs Market Forecast, 2017-2027 7.4.2 France Marine-Derived Drugs Market Forecast, 2017-2027 7.4.3 UK Marine-Derived Drugs Market Forecast, 2017-2027 7.4.4 Spain Marine-Derived Drugs Market Forecast, 2017-2027 7.4.5 Italy Marine-Derived Drugs Market Forecast, 2017-2027 7.4.6 Rest of Europe Marine-Derived Drugs Market Forecast, 2017-2027 7.5 Asia-Pacific Marine-Derived Drugs Market Forecast, 2016-2027 7.5.1 China Marine-Derived Drugs Market Forecast, 2017-2027 7.5.2 Japan Marine-Derived Drugs Market Forecast, 2017-2027 7.5.3 India Marine-Derived Drugs Market Forecast, 2017-2027 7.5.4 Australia Marine-Derived Drugs Market Forecast, 2017-2027 7.5.5 Thailand Marine-Derived Drugs Market Forecast, 2017-2027 7.5.6 Rest of Asia-Pacific Marine-Derived Drugs Market Forecast, 2017-2027 7.6 Rest of World Marine-Derived Drugs Market Forecast, 2017-2027 7.6.1 Middle East Marine-Derived Drugs Market Forecast, 2017-2027 7.6.2 Africa Marine-Derived Drugs Market Forecast, 2017-2027 7.6.3 Other Countries Marine-Derived Drugs Market Forecast, 2017-2027
8. Marine-Derived Drugs Market, Qualitative Analysis, 2017-2027 8.1 Porter’s Five Forces Analysis of the Marine-Derived Drugs Market 2017-2027 8.1.1 Bargaining Power of Buyers (High) 8.1.2 Bargaining Power of Suppliers (Medium) 8.1.3 Threat of New Entrants (Low) 8.1.4 Threat of Substitute Products (Low) 8.1.5 Intensity of Competitive Rivalry (High) 8.2 Drivers & Restrains 8.2.1 Rising Incidence and Prevalence of Various Cancer Types 8.2.2 Increasing Investment from Government, Public and Private Sector 8.2.3 Increasing Clinical Trials 8.2.4 Increasing Popularity of Marine Derived Drugs 8.2.5 Strong Growth in Emerging Markets 8.2.6 New Healthcare Technologies May Enable Marine Derived Drugs Approvals 8.2.7 Large pool of geriatric population and related rise in chronic diseases
9. Leading Companies in Marine-Derived Drugs Market 9.1 Abbott Laboratories Inc. 9.1.1 Abbott Laboratories Inc.: Company Overview 9.1.2 Abbott Laboratories Inc.: Product Portfolio 9.2 GlaxoSmithKline PLC 9.2.1 GlaxoSmithKline PLC: Company Overview 9.2.2 GlaxoSmithKline PLC: Product Portfolio 9.3 Abbvie Inc. 9.3.1 Abbvie Inc.: Company Overview 9.3.2 Abbvie Inc.: Product Portfolio 9.4 Pharma Marine AS 9.4.1 Pharma Marine: Company Overview 9.4.2 Pharma Marine: Product Portfolio 9.5 Takeda Pharmaceutical Company Ltd. (Takeda Oncology’s Millennium) 9.5.1 Takeda Pharmaceutical Company Ltd.: Company Overview 9.5.2 Takeda Pharmaceutical Company Ltd.: Product Portfolio 9.5.3 Takeda Pharmaceutical Company Ltd.: Recent Developments 9.6 Aker BioMarine AS 9.6.1 Aker BioMarine AS: Company Overview 9.6.2 Aker BioMarine AS: Recent Developments 9.7 Marine Polymer Technologies, Inc. 9.7.1 Marine Polymer Technologies, Inc.: Company Overview 9.8 Sea Run Holdings, Inc. 9.8.1 Sea Run Holdings, Inc.: Company Overview 9.8.2 Sea Run Holdings, Inc.: Product Portfolio 9.9 Aphios Corporation 9.9.1 Aphios Corporation: Company Overview 9.9.2 Aphios Corporation: Product Portfolio 9.10 Sanofi S.A. (Sanofi Genzyme) 9.10.1 Sanofi S.A.: Company Overview 9.10.2 Sanofi S.A.: Product Portfolio 9.11 Other Companies of Interest in the Marine Derived Drugs Market
10. Conclusions 10.1 Current Leading Segments 10.2 Leading Regional Markets 10.3 Emerging Markets 10.4 The Future of the Market?
11. Glossary Associated Visiongain Reports Visiongain Report Sales Order Form Appendix A About Visiongain Appendix B Visiongain report evaluation form
List of Figures Figure 3.1 Marine-Derived Drugs Market, by Type, ($m), 2017-2027 Figure 3.2 Marine-Derived Drugs Market, by Source, ($m), 2017-2027 Figure 3.3 Marine-Derived Drugs Market, by Application, ($m), 2017-2027 Figure 4.1 Marine-Derived Drugs Market, by Type (%), 2016 Figure 4.2 Marine-Derived Drugs Market, by Type, Forecast ($m) 2017-2027 Figure 4.3 Global Marine-Derived Phenol Drugs Market Forecast, by Geography, ($m) 2017-2027 Figure 4.4 Global Marine-Derived Steroid Drugs Drugs Market Forecast, by Geography, ($m) 2017-2027 Figure 4.5 Global Marine-Derived Ether Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027 Figure 4.6 Global Marine-Derived Peptide Drugs Market Forecast, by Geography, ($m) 2017-2027 Figure 4.7 Global Other Marine-Derived Drugs Market Forecast, by Geography, ($m) 2017-2027 Figure 5.1 Marine-Derived Drugs Market, by Source, ($m) 2017-2027 Figure 5.2 Marine-Derived Drugs Market, by Source, Market Share (%), 2016 Figure 5.3 Algae-Derived Drugs Market Forecast, by Geography ($m) 2017-2027 Figure 5.4 Invertebrate-Derived Drugs Market Forecast, by Geography($m) 2017-2027 Figure 5.5 Marine Microorganism-Derived Drugs Market, by Geography($m) 2017-2027 Figure 6.1 Marine-Derived Drugs Market Forecast, by Application, ($million) 2017-2027 Figure 6.2 Marine-Derived Drugs Market, by Application, Market Share (%), 2016 Figure 6.3 Marine-Derived Drugs Market Forecast for Anti-microbial, by Geography, ($m) 2017-2027 Figure 6.4 Marine-Derived Drugs Market Forecast for Anti-tumour, by Geography, ($m) 2017-2027 Figure 6.5 Marine-Derived Drugs Market Forecast for Cardiovascular Applications, by Geography, ($m) 2017-2027 Figure 6.6 Marine-Derived Drugs Market Forecast for Anti-viral, by Geography, ($m) 2017-2027 Figure 6.7 Marine-Derived Drugs Market Forecast for Anti-Inflammatory, by Geography, ($m) 2017-2027 Figure 6.8 Marine-Derived Drugs Market Forecast for Other Indications, by Geography ($m) 2017-2027 Figure 7.1 Global Marine-Derived Drugs Market Forecast, by Geography($m) 2017-2027 Figure 7.2 Global Marine-Derived Drugs Market Forecast, by Geography, Market Share (%), 2016 Figure 7.3 North America Marine-Derived Drugs Market Forecast, by Country, ($m), 2017-2027 Figure 7.4 North America Marine-Derived Drugs Market Forecast, by Geography, Market Share (%), 2016 Figure 7.5 USA Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.6 Canada Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.7 Mexico Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.8 South America Marine-Derived Drugs Market Forecast, by Country($m) 2017-2027 Figure 7.9 South America Marine-Derived Drugs Market, by Country, Market Share (%), 2016 Figure 7.10 Brazil Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.11 Argentina Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.12 Paraguay Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.13 Bolivia Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.14 Rest of South America Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.15 Europe Marine-Derived Drugs Market Forecast, by Country($m) 2017-2027 Figure 7.16 Europe Marine-Derived Drugs Market, by Country, Market Share (%), 2016 Figure 7.17 Germany Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.18 France Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.19 UK Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.20 Spain Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.21 Italy Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.22 Rest of Europe Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.23 Asia-Pacific Marine-Derived Drugs Market Forecast, by Country($million) 2017-2027 Figure 7.24 Asia-Pacific Marine-Derived Drugs Market, Market Share (%), 2016 Figure 7.25 China Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.26 Japan Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.27 India Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.28 Australia Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.29 Thailand Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.30 Rest of Asia-Pacific Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.31 RoW Marine-Derived Drugs Market Forecast, by Country($m) 2017-2027 Figure 7.32 Rest of World Marine-Derived Drugs Market, by Country, Market Share (%), 2016 Figure 7.33 Middle East Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.34 Africa Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 7.35 Other Countries Marine-Derived Drugs Market Forecast ($m) 2017-2027 Figure 8.1 Porter’s Five Forces Analysis of the Marine-Derived Drugs Market Figure 9.1 Abbott Laboratories Inc., Revenue, ($million), 2012-2016 Figure 9.2 Abbott Laboratories Inc., Geographic Presence Share (%), 2016 Figure 9.3 GlaxoSmithKline PLC, Revenue, ($million), 2012-2016 Figure 9.4 GlaxoSmithKline PLC, Product Segments Share (%), 2016 Figure 9.5 GlaxoSmithKline PLC, Geographical Presence Share (%), 2016 Figure 9.6 Abbvie Inc., Revenue, ($million), 2012-2016 Figure 9.7 Abbvie Inc.,Product Segments Share (%), 2016 Figure 9.8 Abbvie Inc., Geographical Presence Share (%), 2016 Figure 9.9 Takeda Pharmaceutical Company Ltd., Revenue, ($million), 2012-2016 Figure 9.10 Aker BioMarine AS, Revenue, ($million), 2012-2016 Figure 9.11 Aker BioMarine AS., Geographical Presence Share (%), 2016 Figure 9.12 Sanofi S.A., Revenue, ($million), 2012-2016 Figure 9.13 Sanofi S.A., Product Segments Share (%), 2016 Figure 9.14 Sanofi S.A., Geographical Presence Share (%), 2016 Figure 10.1 World Marine-Derived Drugs, by Type, ($million), 2017-2027 Figure 10.2 World Marine-Derived Drugs, by Sources, ($million), 2017-2027 Figure 10.3 World Marine-Derived Drugs, by End-User, ($million), 2017-2027 Figure 10.4 World Marine-Derived Drugs, by Geography, ($million), 2017-2027
List of Tables Table 3.1. Marine-Derived Drugs Market Forecast ($m, AGR%) 2017-2027 Table 4.1. Marine-Derived Drugs Market Forecast, by Type ($m, AGR%) 2017-2027 Table 4.2 Global Marine-Derived Phenol Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 4.3 Marine-Derived Phenol Drugs Market Forecast, by Geography, ($m, AGR%) 2017-2027 Table 4.4 Global Marine-Derived Steroid Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 4.5 Global Marine-Derived Steroid Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027 Table 4.6 Global Marine-Derived Ether Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 4.7 Global Marine-Derived Ether Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027 Table 4.8 Global Marine-Derived Peptide Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 4.9 Global Marine-Derived Peptide Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027 Table 4.10 Global Other Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 4.11 Global Other Marine-Derived Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027 Table 5.1 Marine-Derived Drugs Market, by Source ($m, AGR%) 2017-2027 Table 5.2 Algae-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 5.3 Algae-Derived Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027 Table 5.4 Invertebrate-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 5.5 Invertebrate-Derived Drugs Market Forecast, by Geography ($m, AGR%) 2017-2027 Table 5.6 Marine Microorganism-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 5.7 Marine Microorganism-Derived Drugs Market, by Geography ($m, AGR%) 2017-2027 Table 6.1 Marine-Derived Drugs Market, by Application($m, AGR%) 2017-2027 Table 6.2 Marine-Derived Drugs Market Forecast for Anti-Microbial Applications ($m, AGR%) 2017-2027 Table 6.3 Marine-Derived Drugs Market Forecast for Anti-microbial, by Geography ($m, AGR%), 2017-2027 Table 6.4 Marine-Derived Drugs Market Forecast for Anti-Microbial ($m, AGR%) 2017-2027 Table 6.5 Marine-Derived Drugs Market Forecast for Anti-tumour, by Geography ($m, AGR%) 2017-2027 Table 6.6 Marine-Derived Drugs Market Forecast for Cardiovascular Applications, ($m, AGR%) 2017-2027, Table 6.7 Marine-Derived Drugs Market Forecast for Cardiovascular Applications, by Geography ($m, AGR%) 2017-2027 Table 6.8 Marine-Derived Drugs Market Forecast for Anti-viral ($m, AGR%) 2017-2027 Table 6.9 Marine-Derived Drugs Market Forecast for Anti-viral, by Geography ($m, AGR%) 2017-2027 Table 6.10 Marine-Derived Drugs Market Forecast for Anti- inflammatory ($m, AGR%) 2017-2027 Table 6.11 Marine-Derived Drugs Market Forecast for Anti-Inflammatory, by Geography ($m. AGR%) 2017-2027 Table 6.12 Marine-Derived Drugs Market for Other Indications, ($m, AGR%) 2017-2027 Table 6.13 Marine-Derived Drugs Market Forecast for Other Indications, by Geography ($m, AGR%) 2017-2027 Table 7.1 Marine-Derived Drugs Market Forecast by Geography ($m, AGR%) 2017-2027 Table 7.2 North America Marine-Derived Drugs Market Forecast, by Country, ($m, AGR%), 2017-2027 Table 7.3 USA Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.4 Canada Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.5 Mexico Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.6 South America Marine-Derived Drugs Market Forecast, by Country ($m, AGR%) 2017-2027 Table 7.7 Brazil Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.8 Argentina Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.9 Paraguay Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.10 Bolivia Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.11 Rest of South America Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.12 European Marine-Derived Drugs Market Forecast, by Country ($m, AGR%) 2017-2027 Table 7.13 Germany Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.14 France Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.15 UK Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.16 Spain Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.17 Italy Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.18 Rest of European Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.19 Asia-Pacific Marine-Derived Drugs Market Forecast, by Country ($m, AGR%) 2017-2027 Table 7.20 China Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.21 Japan Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.22 India Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.23 Australia Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.24 Thailand Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.25 Rest of Asia-Pacific Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.26 Rest of World Marine-Derived Drugs Market Forecast, by Country ($m, AGR%) 2017-2027 Table 7.27 Middle East Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.28 Africa Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 7.29 Other Countries Marine-Derived Drugs Market Forecast, ($m, AGR%) 2017-2027 Table 8.2 Worldwide Estimated Incidence and Prevalence of all Cancer Types, (2012) Table 9.1 Abbott Laboratories Inc.: Company Overview Table 9.2 Abbott Laboratories Inc.: Product Portfolio Table 9.3 GlaxoSmithKline PLC: Company Overview Table 9.4 GlaxoSmithKline PLC: Product Portfolio Table 9.5 Abbvie Inc.: Company Overview Table 9.6 Abbvie Inc.: Product Portfolio Table 9.7 Pharma Marine: Company Overview Table 9.8 Pharma Marine: Product Portfolio Table 9.9 Takeda Pharmaceutical Company Ltd.: Company Overview Table 9.10 Takeda Pharmaceutical Company Ltd.: Product Portfolio Table 9.11 Takeda Pharmaceutical Company Ltd.: Recent Developments Table 9.12 Aker BioMarine AS: Company Overview Table 9.13 Aker BioMarine AS: Recent Developments Table 9.14 Marine Polymer Technologies, Inc.: Company Overview Table 9.15 Sea Run Holdings, Inc.: Company Overview Table 9.16 Sea Run Holdings, Inc.: Product Portfolio Table 9.17 Aphios Corporation: Company Overview Table 9.18 Aphios Corporation: Product Portfolio Table 9.19 Sanofi S.A.: Company Overview Table 9.20 Sanofi S.A.: Product Portfolio Table 9.21 Other Companies of Interest in the Marine Derived Drugs Market Table 9.21 Other Companies of Interest in the Marine Derived Drugs Market (continued)
Abbott Laboratories AbbVie, Inc. Alkermes Plc Amarin Corp. Plc Amgen, Inc. Amnis Corporation Aphios Corporation Array BioPharma, Inc. Associates Of Cape Cod Inc. Astex Pharmaceuticals Inc. AstraZeneca Plc ASYMPTOTE LTD Bayer AG Bayer Corporation Bayer HealthCare AG Bayer Schering Pharma Aktiengesellschaft BioMarin Pharmaceutical, Inc. Biotest AG Bristol-Myers Squibb Co. Cardax, Inc. Ceapro, Inc. Celgene Corp. Centene Corp. Cephalon, Inc. Chugai Pharmaceutical Co., Ltd. CK Life Sciences International (Holdings), Inc. CTI BioPharma Corp. Deroyal Industries Inc. Domain Therapeutics SA Emd Millipore Corporation Emd Serono Inc. Endo International Plc Evotec AG GE HEALTHCARE LTD GlaxoSmithKline Plc Henry Schein, Inc. International Medical Corps Janssen Biotech, Inc. JHL Biotech, Inc. Johnson & Johnson Laboratoire Theramex Lombard Medical, Inc. Lonza Group AG Marine Polymer Technology Medtronic Plc Merck KGaA MorphoSys AG Myrexis, Inc. NBTY, Inc. Neptune Technologies & Bioresources, Inc. Nexvet Biopharma PLC Nordion Inc Novartis AG Opexa Therapeutics, Inc. Otsuka Pharmaceutical Co. Ltd. Panacos Pharmaceuticals, Inc. PELICAN HEALTHCARE LTD Pfizer Inc. Pharma Mar SA Polymer Technology Systems Inc. Premier Healthcare Alliance L.P. Progyny Inc. Quanterix Corp. Samsung BioLogics Co., Ltd. Sangers (Northern Ireland) Limited Sanofi Sea Run Holdings Spectrum Pharmaceuticals, Inc. T G EAKIN LTD Taiho Pharmaceutical Co. Ltd. Takeda Pharmaceutical Co., Ltd. UnitedHealth Group, Inc. Verastem, Inc. Vertex Pharmaceuticals, Inc. VWR International, LLC Windtree Therapeutics, Inc. Zogenix, Inc.
List of Organizations Australian Institute Of Health And Welfare European Medicines Agency Food Drug and Administration Health Canada Ministry of Health, Labor and Welfare National Cancer Institute The American Society Of Clinical Oncology Inc The Feinstein Institute For Medical Research United States Department Of Health & Human Services World Health Organization
Download sample pages
Complete the form below to download your free sample pages for World Marine Derived Drugs Market Forecast 2017-2027
Download sample pages
Complete the form below to download your free sample pages for World Marine Derived Drugs Market Forecast 2017-2027
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global Bioreactors market was estimated to be valued at US$ 9,9770.0 million in 2023 and is expected to register a CAGR of 12.2% from 2023 to 2033.
Visiongain Publishes 3D Printing for Healthcare Market Report 2023-2033
The global 3D Printing for Healthcare market was valued at US$2,970.7 million in 2022 and is projected to grow at a CAGR of 23.6% during the forecast period 2023-2033.
Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2023-2033
The global Clinical Trial Supply and Logistics for Pharma market is valued at US$13.8 billion in 2023 and is projected to grow at a CAGR of 8.4% during the forecast period 2023-2033.
The global Anti-infective Vaccines market is valued at US$48,360.4 million in 2023 and is projected to grow at a CAGR of 6.6% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
